Nature,
Journal Year:
2023,
Volume and Issue:
626(7998), P. 419 - 426
Published: Dec. 5, 2023
Abstract
Determining
the
structure
and
phenotypic
context
of
molecules
detected
in
untargeted
metabolomics
experiments
remains
challenging.
Here
we
present
reverse
as
a
discovery
strategy,
whereby
tandem
mass
spectrometry
spectra
acquired
from
newly
synthesized
compounds
are
searched
for
public
datasets
to
uncover
associations.
To
demonstrate
concept,
broadly
explored
multiple
classes
metabolites
humans,
including
N
-acyl
amides,
fatty
acid
esters
hydroxy
acids,
bile
conjugated
acids.
Using
repository-scale
analysis
1,2
,
discovered
that
some
acids
associated
with
inflammatory
bowel
disease
(IBD).
Validation
using
four
distinct
human
IBD
cohorts
showed
cholic
Glu,
Ile/Leu,
Phe,
Thr,
Trp
or
Tyr
increased
Crohn’s
disease.
Several
these
related
structures
affected
pathways
IBD,
such
interferon-γ
production
CD4
+
T
cells
3
agonism
pregnane
X
receptor
4
.
Culture
bacteria
belonging
Bifidobacterium
Clostridium
Enterococcus
genera
produced
amidates.
Because
searching
repositories
has
only
recently
become
possible,
this
approach
can
now
be
used
general
strategy
discover
other
animal
ecosystems.
Physiological Reviews,
Journal Year:
2020,
Volume and Issue:
101(2), P. 683 - 731
Published: Aug. 13, 2020
Several
diseases
and
conditions
have
been
associated
with
an
uncontrolled
rise
in
bile
acid
(BA)
concentrations.
This
is
often
the
case
when
tight
feedback
regulation
of
BA
synthesis
compromised
to
point
that
BAs
become
detrimental.
their
cognate
receptors,
farnesoid
X
receptor
(FXR)
Takeda
G-protein
5
(TGR5),
however,
exert
many
beneficial
roles
as
they
enable
tissues
adapt
environmental,
nutritional,
physiological
cues.
Over
last
two
decades,
mimetics
targeting
FXR,
TGR5,
or
both,
proven
be
efficacious
alleviating
chronic
metabolic
inflammatory
disorders,
such
obesity,
Type
2
diabetes
(T2D),
atherosclerosis
non-alcoholic
steatohepatitis
(NASH).
While
several
aspects
signaling
are
still
poorly
understood,
first
therapeutics
FXR
making
way
into
clinic
treat
liver
diseases,
primary
biliary
cholangitis
(PBC)
NASH.
Drugs
may,
hence,
a
bright
future
continuing
efforts
on
studying
impact
changing
pathways
humans
will
translate
our
emerging
knowledge
physiology
model
organisms
clinical
benefits.
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Oct. 5, 2020
Abstract
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
associated
with
obesity
but
also
found
in
non-obese
individuals.
Gut
microbiome
profiles
of
171
Asians
biopsy-proven
NAFLD
and
31
non-NAFLD
controls
are
analyzed
using
16S
rRNA
sequencing;
an
independent
Western
cohort
used
for
external
validation.
Subjects
classified
into
three
subgroups
according
to
histological
spectra
or
fibrosis
severity.
Significant
alterations
diversity
observed
severity
non-obese,
not
obese,
subjects.
Ruminococcaceae
Veillonellaceae
the
main
microbiota
Furthermore,
stool
bile
acids
propionate
elevated,
especially
subjects
significant
fibrosis.
Fibrosis-related
species
undergo
metagenome
sequencing,
four
representative
administered
mouse
models
evaluate
their
effects
on
damage.
This
study
provides
evidence
role
pathogenesis,
Gastroenterology,
Journal Year:
2020,
Volume and Issue:
159(3), P. 956 - 968.e8
Published: May 30, 2020
Renewal
and
patterning
of
the
intestinal
epithelium
is
coordinated
by
stem
cells
(ISCs);
dietary
metabolic
factors
provide
signals
to
niche
that
control
ISC
activity.
Bile
acids
(BAs),
metabolites
in
gut,
signal
nutrient
availability
activating
G
protein-coupled
bile
acid
receptor
1
(GPBAR1,
also
called
TGR5).
TGR5
expressed
epithelium,
but
it
not
clear
how
its
activation
affects
ISCs
regeneration
epithelium.
We
studied
role
BAs
renewal,
regulation
function
mice
organoids.We
derived
organoids
from
wild-type
Tgr5-/-
mice,
incubated
them
with
or
agonist
INT-777,
monitored
morphologic
analyses
colony-forming
assays.
disrupted
Tgr5
specifically
Lgr5-positive
(Tgr5ISC-/-
mice)
analyzed
number,
proliferation,
differentiation
flow
cytometry,
immunofluorescence,
organoid
Tgr5ISC-/-
were
given
cholecystokinin;
we
measured
effects
BA
release
into
lumen
on
cell
renewal.
induced
colitis
administration
dextran
sulfate
sodium;
disease
severity
was
determined
based
body
weight,
colon
length,
histopathology
analysis
biopsies.BAs
agonists
promoted
growth
organoids.
Administration
cholecystokinin
resulted
acute
increased
proliferation
expression
required
for
homeostatic
epithelial
renewal
fate
specification,
after
induction.
developed
more
severe
than
without
disruption
ISCs.
INT-777
yes-associated
protein
(YAP1)
upstream
regulator
SRC.
Inhibitors
YAP1
SRC
prevented
activation.BAs
promote
via
ISCs,
resulting
YAP
their
target
genes.
Release
endogenous
sufficient
drives
response
injury.
Protein & Cell,
Journal Year:
2020,
Volume and Issue:
12(5), P. 331 - 345
Published: June 29, 2020
ABSTRACT
Inflammatory
bowel
disease
(IBD)
has
become
a
global
with
accelerating
incidence
worldwide
in
the
21st
century
while
its
accurate
etiology
remains
unclear.
In
past
decade,
gut
microbiota
dysbiosis
consistently
been
associated
IBD.
Although
many
IBD-associated
have
not
proven
to
be
cause
or
an
effect
of
IBD,
it
is
often
hypothesized
that
at
least
some
alteration
microbiome
protective
causative.
this
article,
we
selectively
reviewed
hypothesis
supported
by
both
association
studies
human
and
pathogenesis
biological
models.
Specifically,
potential
bacterial
pathways
species
against
as
well
causative
We
also
roles
members
mycobiome
virome
Lastly,
covered
current
status
therapeutic
approaches
targeting
microbiome,
which
promising
strategy
alleviate
cure
inflammatory
disease.
Annual Review of Medicine,
Journal Year:
2021,
Volume and Issue:
73(1), P. 455 - 468
Published: Sept. 23, 2021
Inflammatory
bowel
diseases
(IBD)
arise
from
a
convergence
of
genetic
risk,
environmental
factors,
and
gut
microbiota,
where
each
is
necessary
but
not
sufficient
to
cause
disease.
Emerging
evidence
supports
bidirectional
relationship
between
disease
progression
changes
in
microbiota
membership
function.
Thus,
the
study
microbiome
host-microbe
interactions
should
provide
critical
insights
into
pathogenesis
as
well
leads
for
developing
microbiome-based
diagnostics
interventions
IBD.
In
this
article,
we
review
most
recent
advances
understanding
IBD
highlight
importance
going
beyond
establishing
description
association
gain
mechanistic
causes
consequences
The
aims
contextualize
findings
form
conceptional
frameworks
etiopathogenesis
future
development
interventions.
Journal for ImmunoTherapy of Cancer,
Journal Year:
2021,
Volume and Issue:
9(12), P. e003334 - e003334
Published: Dec. 1, 2021
The
gut
microbiome
is
associated
with
the
response
to
immunotherapy
for
different
cancers.
However,
impact
of
on
hepatobiliary
cancers
receiving
remains
unknown.
This
study
aims
investigate
relationship
between
and
clinical
anti-programmed
cell
death
protein
1
(PD-1)
in
patients
advanced
cancers.Patients
unresectable
hepatocellular
carcinoma
or
biliary
tract
who
have
progressed
from
first-line
chemotherapy
(gemcitabine
plus
cisplatin)
were
enrolled.
Fresh
stool
samples
collected
before
during
anti-PD-1
treatment
analyzed
metagenomic
sequencing.
Significantly
differentially
enriched
taxa
prognosis
identified.
Kyoto
Encyclopedia
Genes
Genomes
database
MetaCyc
further
applied
annotate
explore
potential
mechanism
influencing
cancer
immunotherapy.In
total,
65
included
this
study.
Seventy-four
significantly
benefit
(CBR)
group
40
non-clinical
(NCB)
group.
Among
these
taxa,
higher
abundance
Lachnospiraceae
bacterium-GAM79
Alistipes
sp
Marseille-P5997,
which
CBR
group,
achieved
longer
progression-free
survival
(PFS)
overall
(OS)
than
lower
abundance.
Higher
Ruminococcus
calidus
Erysipelotichaceae
bacterium-GAM147
was
also
observed
better
PFS.
In
contrast,
worse
PFS
OS
found
Veillonellaceae,
NCB
Functional
annotation
indicated
that
energy
metabolism
while
amino
acid
metabolism,
may
modulate
addition,
immunotherapy-related
adverse
events
affected
by
diversity
relative
abundance.We
demonstrate
Taxonomic
signatures
responders
are
effective
biomarkers
predict
immunotherapy,
might
provide
a
new
therapeutic
target
immunotherapy.